AMS

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities during an offer period. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities. No financial details or deal terms are provided in the article.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. The filing signals that Advanced Medical Solutions Group is in an active offer period.

A Form 8.3 disclosure has been filed in relation to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities. Form 8.3 filings are regulatory requirements under UK takeover rules when a party holds 1% or more of a class of relevant securities. No specific transaction details or deal terms are provided in the article.

Octopus Investments has filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated June 17, 2026, by CGWL. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing M&A activity surrounding Advanced Medical Solutions Group PLC.

Advanced Medical Solutions Group published a brief release via GlobalNewswire containing only a numerical value of 8.3, with no additional context, financial details, or narrative provided. The content is insufficient to determine the nature or significance of the announcement. No actionable information can be extracted from the article as published.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. The filing signals that Advanced Medical Solutions Group is in an active offer period.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated June 16, 2026, by CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing M&A activity surrounding Advanced Medical Solutions Group PLC.

Octopus Investments has filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

Advanced Medical Solutions Group published a brief release via GlobalNewswire containing only a numerical value of 8.3, with no additional context, financial details, or narrative provided. The content is insufficient to determine the nature or significance of the announcement. No actionable information can be extracted from the article as published.

Advanced Medical Solutions Group published a brief release via GlobalNewswire containing only a numerical value of 8.3, with no additional context, financial details, or narrative provided. The content is insufficient to determine the nature or significance of the announcement. No actionable information can be extracted from the article as published.

Octopus Investments has filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or change in position in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK takeover rules when a party holds 1% or more of a class of securities in a company subject to an offer. This is a routine disclosure filing with no new operational or financial information provided.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated June 12, 2026. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeree or offeror company during an offer period. The filing indicates Advanced Medical Solutions Group PLC is subject to an active offer or takeover situation.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a relevant interest in the company's securities during an offer period. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. No financial terms or transaction details are provided in the filing.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated June 11, 2026, by CGWL. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a person holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing M&A activity surrounding Advanced Medical Solutions Group PLC.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities under UK takeover rules. Form 8.3 filings are required when a party holds 1% or more of a class of relevant securities during an offer period. No details of the specific position size or transaction are provided in the headline.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed in relation to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities. Form 8.3 filings are regulatory disclosures required when a party holds 1% or more of a class of securities in an offer situation. No financial details or transaction specifics are provided in the article.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities under UK takeover rules. Form 8.3 filings are required when a party holds 1% or more of a class of relevant securities during an offer period. No details of the specific position size or transaction are provided in the headline.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. This is a routine disclosure filing with no new fundamental information about Advanced Medical Solutions' business or financials.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, as reported via GlobalNewswire. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of securities in an offeree or offeror company during an offer period. The filing indicates that Advanced Medical Solutions Group PLC is subject to an active offer or takeover situation.

Octopus Investments filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or change in position in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities during an offer period. Form 8.3 filings are regulatory disclosures required when a party holds 1% or more of a class of relevant securities during a takeover or merger situation. No further details on the nature or size of the position are provided in the article.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, indicating a party holds a relevant interest or dealing in the company's securities as required under UK takeover rules. Form 8.3 filings are mandatory public disclosures when a person holds 1% or more of a class of securities in a company subject to a takeover offer. The filing itself contains no new fundamental information about the company's operations or financials.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. The filing signals that Advanced Medical Solutions Group is in an active offer period.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or interests in relevant securities as required under takeover rules. Form 8.3 filings are mandatory regulatory disclosures during offer periods when a party holds 1% or more of a class of relevant securities. No financial details or deal terms are provided in the article.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 05 June 2026, submitted by CGWL. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing M&A activity involving Advanced Medical Solutions Group PLC.

Octopus Investments filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or change in position in the company's shares. Form 8.3 is a regulatory disclosure required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine regulatory filing with no new fundamental information about the company's operations or financials.

Octopus Investments has filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, indicating a party holds a relevant interest or dealing in the company's securities during a UK takeover offer period. The filing was made by CGWL and relates to activity dated June 2, 2026. Form 8.3 is a regulatory disclosure required under UK Takeover Panel rules when a person holds 1% or more of a class of securities in an offeror or offeree company.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. The filing is procedural in nature and reflects position disclosure rather than a new strategic action.

A Form 8.3 disclosure has been filed in relation to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities. Form 8.3 filings are regulatory disclosures required when a party holds 1% or more of a class of securities in a company subject to a takeover offer. No financial terms or deal details are provided in this filing.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, indicating a party holds or has dealt in a relevant interest in the company's securities during an offer period. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeror or offeree company. No financial details or deal terms are provided in the filing.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities. Form 8.3 filings are regulatory requirements under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. No financial details or transaction specifics are provided in the article.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a publicly disclosed interest or change in position in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 29 May 2026, by CGWL. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing M&A activity involving Advanced Medical Solutions Group PLC.

A Form 8.3 correction has been filed regarding Advanced Medical Solutions Group PLC, relating to purchase and sale detail dated 28 May 2026. Form 8.3 is a regulatory disclosure required when a party holds 1% or more of a company's securities during an offer period. This is a corrective amendment to a previously submitted filing.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities. Form 8.3 filings are regulatory disclosures required when a party holds 1% or more of a class of securities during an offer period. No financial details or transaction specifics are provided in the article.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. The filing signals that Advanced Medical Solutions Group is in an active offer period.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated May 28, 2026, by CGWL. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a person holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing M&A activity surrounding Advanced Medical Solutions Group PLC.

A Form 8.3 disclosure has been filed in relation to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities. Form 8.3 filings are regulatory requirements under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. No financial terms or deal details are provided in this filing.

Octopus has filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a publicly disclosed interest or change in position in the company's securities. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. This filing suggests Advanced Medical Solutions Group is currently subject to a takeover offer period.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 27 May 2026, by CGWL. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeree or offeror company during an offer period. The filing indicates Advanced Medical Solutions Group PLC is subject to an active takeover offer period.

A Form 8.3 disclosure has been filed by CGAML regarding Advanced Medical Solutions Group PLC, dated May 26, 2026. Form 8.3 is a regulatory disclosure required when a person holds 1% or more of a company's securities during an offer period. The filing is a standard regulatory transparency requirement and contains no new fundamental corporate news.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities during an offer period. The filing is a regulatory disclosure requirement and contains no new fundamental business information. No financial details or deal terms are provided in the article.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. The filing signals that Advanced Medical Solutions Group is in an active offer period.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK takeover rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. This is a routine disclosure filing with no new fundamental information about Advanced Medical Solutions' business or financials.

A Form 8.3 disclosure has been filed by CGAML regarding Advanced Medical Solutions Group PLC, dated 22 May 2026. Form 8.3 is a regulatory disclosure required when a person holds 1% or more of a company's securities during an offer period. No financial results or strategic developments are reported in this filing.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's securities. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. The filing signals that Advanced Medical Solutions Group is in an active offer period under the UK Takeover Panel's jurisdiction.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities. Form 8.3 filings are regulatory requirements under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. No financial details or transaction specifics are provided in the article.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

Octopus has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a reportable interest or dealing in the company's shares under UK takeover disclosure rules. Form 8.3 filings are required when a party holds 1% or more of a class of relevant securities during an offer period. No financial terms or transaction details are provided in the filing summary.

A Form 8.3 disclosure has been filed by CGAML regarding Advanced Medical Solutions Group PLC, dated 21 May 2026. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeror or offeree company during an offer period. The filing indicates ongoing market activity in AMS shares during a live offer period.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities by a party holding 1% or more of a relevant class. Form 8.3 filings are regulatory disclosures required under UK Takeover Code rules during offer periods. No financial details or deal terms are provided in the filing excerpt.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. This is a routine regulatory disclosure with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities by a party holding 1% or more of a relevant class. Form 8.3 filings are regulatory disclosures required under UK Takeover Code rules during offer periods. No financial details or transaction specifics are provided in the article body.

A Form 8.3 disclosure has been filed by CGAML regarding Advanced Medical Solutions Group PLC, dated 15 May 2026. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing market activity in AMS shares in the context of a takeover situation.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a relevant interest in the company's securities during a takeover or merger situation. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in an offeror or offeree company. No financial terms or transaction details are provided in the filing.

A Form 8.3 regulatory disclosure has been filed relating to Advanced Medical Solutions Group. Form 8.3 is a standard UK regulatory filing required when a party holds 1% or more of a company involved in a takeover offer, disclosing dealings in relevant securities. No financial results or operational updates are included in this filing.

A Form 8.3 disclosure has been filed by CGAML regarding Advanced Medical Solutions Group PLC, dated 14 May 2026. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeror or offeree company during an offer period. The filing indicates ongoing market activity in AMS shares during a live offer period.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 14 May 2026, submitted by CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing market activity in AMS shares in the context of a takeover situation.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine disclosure filing with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 13 May 2026, by CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing market activity in Advanced Medical Solutions Group PLC shares during a potential offer period.

Octopus has filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under the UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine regulatory disclosure with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed relating to Advanced Medical Solutions Group, indicating a public opening position or interests in relevant securities as required under takeover disclosure rules. Form 8.3 filings are regulatory requirements during offer periods and provide transparency on holdings above the 1% threshold. No financial results or operational updates are included in this filing.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 12 May 2026, submitted via CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeree or offeror company during an offer period. The filing indicates ongoing market activity or position-holding in Advanced Medical Solutions Group PLC during an active offer period.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a relevant interest in the company's securities during an offer period. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. No financial details or transaction specifics are provided in the available text.

A Form 8.3 regulatory disclosure has been filed regarding Advanced Medical Solutions Group. Form 8.3 is a standard UK takeover-related disclosure of interests in relevant securities. No additional deal terms or material new information are provided in the article body.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. This is a routine regulatory disclosure with no new fundamental information about Advanced Medical Solutions.

A Form 8.3 regulatory disclosure has been filed regarding Advanced Medical Solutions Group. Form 8.3 is a standard UK regulatory filing required when a party holds 1% or more of a company's shares during an offer period. No material new information beyond the filing itself is provided in the article.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a relevant interest in the company's securities during an offer period. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. No financial details or transaction specifics are provided in the available text.

A Form 8.3 disclosure has been filed by CGAML regarding Advanced Medical Solutions Group PLC, dated 11 May 2026. Form 8.3 is a regulatory requirement under UK Takeover Code rules, indicating the filer holds an interest in relevant securities during an offer period. No financial details or position size are provided in the available text.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 11 May 2026, submitted via CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeror or offeree company during an offer period. The filing indicates ongoing market activity in Advanced Medical Solutions Group PLC shares during an active offer period.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine regulatory disclosure with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed relating to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities by a party holding 1% or more of a relevant class of shares. Form 8.3 filings are regulatory requirements under the UK Takeover Code during an offer period. No financial figures or deal terms are provided in the article body.

A Form 8.3 regulatory disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated May 8, 2026, submitted by CGWL. Form 8.3 is a mandatory public disclosure of interests or short positions in a company subject to a UK takeover offer. The filing indicates a relevant party holds or has dealt in a position in Advanced Medical Solutions Group PLC during an active offer period.

Octopus has filed a Form 8.3 disclosure related to Advanced Medical Solutions Group plc, indicating a reportable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. This is a routine regulatory disclosure with no new fundamental information about the company's operations or financials.

A Form 8.3 disclosure has been filed relating to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities by a party with an interest of 1% or more. Form 8.3 filings are regulatory disclosures required under UK Takeover Code rules during an offer period. No financial details or deal terms are provided in the article body.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. This is a routine regulatory disclosure with no new fundamental information about Advanced Medical Solutions.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 07 May 2026, submitted by CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in an offeree or offeror company during an offer period. The filing indicates ongoing market activity or position-holding in Advanced Medical Solutions Group PLC during an active offer period.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. The filing signals that Advanced Medical Solutions Group is in an active offer period.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. This is a routine regulatory disclosure with no new fundamental information about Advanced Medical Solutions.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated 06 May 2026, submitted by CGWL. Form 8.3 is a regulatory requirement under UK Takeover Code rules, indicating the filer holds a material interest in a company subject to a takeover offer or merger situation. No additional deal terms or financial details are provided in the filing summary.

A Form 8.3 (public opening position disclosure) has been filed in relation to Advanced Medical Solutions Group. This is a regulatory disclosure required under takeover rules when a party holds an interest of 1% or more in an offeree or offeror company. No financial details or deal terms are provided in the filing excerpt.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. The filing is procedural and provides transparency on positions held during a potential or ongoing corporate transaction.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group PLC, dated May 5, 2026, submitted via CGWL. Form 8.3 is a regulatory requirement under UK Takeover Code rules, indicating the filer holds a material interest in an offeree or offeror company during an offer period. The filing itself contains no additional detail beyond the header in the provided text.

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure related to Advanced Medical Solutions ordinary shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. This is a routine regulatory disclosure with no new fundamental information about Advanced Medical Solutions.

A Form 8.3 disclosure has been filed relating to Advanced Medical Solutions Group, indicating a party holds or has dealt in a relevant interest in the company during an offer period. Form 8.3 filings are regulatory disclosures required under UK takeover rules when a person holds 1% or more of a class of securities in an offeror or offeree company. No financial details or deal terms are provided in the article.

A Form 8.3 disclosure has been filed relating to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities by a party holding an interest in the context of a relevant transaction. Form 8.3 filings are regulatory disclosures required under UK Takeover Code when a person holds 1% or more of a class of relevant securities. No specific transaction details or position sizes are provided in the available text.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code when a party holds 1% or more of a class of relevant securities during an offer period. The filing is procedural and provides transparency on positions held during a potential or ongoing corporate transaction.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions PLC, dated May 1, 2026, submitted by CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. No financial details or position changes are provided in the article body.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's shares. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities during an offer period. The filing is procedural and provides transparency on positions held by market participants during a potential corporate action.

A Form 8.3 disclosure has been filed relating to Advanced Medical Solutions Group, indicating a party holds a relevant interest or dealing in the company's securities during an offer period. Form 8.3 filings are regulatory disclosures required when a person holds 1% or more of a class of securities subject to a takeover offer. No financial details or deal terms are provided in the article.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions PLC, dated 30 April 2026, by CGWL. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a person holds 1% or more of a class of securities in a company subject to a takeover offer. The filing indicates ongoing market activity in AMS shares during a live offer period.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a disclosable interest or dealing in the company's shares during an offer period. Form 8.3 is a regulatory filing required under UK Takeover Code rules when a party holds 1% or more of a class of relevant securities. No financial terms or transaction details are provided in the filing headline.

A Form 8.3 disclosure has been filed relating to Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities by a party holding an interest in the offer. Form 8.3 filings are regulatory requirements under UK Takeover Code when a person holds 1% or more of a class of relevant securities. No financial figures or deal terms are provided in the article body.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions PLC, indicating a party holds a relevant interest or dealing in the company's securities as of April 29, 2026. Form 8.3 is a regulatory requirement under UK Takeover Code rules when a person holds 1% or more of a class of securities during an offer period. The filing was made by CGWL.

Octopus Investments has filed a Form 8.3 disclosure relating to Advanced Medical Solutions Group plc, indicating a relevant interest in the company's securities during an offer period. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules when a party holds 1% or more of a class of securities in a company subject to a takeover offer. No financial details or transaction specifics are provided in the available text.

A Form 8.3 disclosure has been filed regarding Advanced Medical Solutions Group, indicating a public opening position or dealing in the company's securities by a party holding 1% or more of a relevant class of shares. Form 8.3 is a regulatory disclosure required under UK Takeover Code rules during an offer period. No financial figures or deal terms are provided in the filing excerpt.

A Form 8.3 regulatory disclosure has been filed regarding Advanced Medical Solutions Group, indicating a party holds or has dealt in a relevant interest in the company during an offer period. Form 8.3 filings are standard regulatory requirements under UK takeover rules and do not indicate a directional corporate event on their own. No financial figures or deal terms are provided in the article.

A Form 8.3 regulatory disclosure has been filed regarding Advanced Medical Solutions PLC, dated April 23, 2026, submitted by CGWL. Form 8.3 is a mandatory public disclosure required when a person holds interests or short positions of 1% or more in a company subject to a takeover offer. The filing indicates market activity related to Advanced Medical Solutions PLC's outstanding offer period.

A Form 8.3 regulatory disclosure has been filed regarding Advanced Medical Solutions Group. Form 8.3 is a mandatory public opening position disclosure required under UK takeover rules when a party holds 1% or more of a class of relevant securities. No financial figures or deal terms are detailed in the available text.